A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and ...

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by ...

A new review by researchers at Oregon Health & Science University’s Knight Cancer Institute and other universities highlights how advances in New Approach Methodologies and tissue engineering are ...

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer ...

Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...

Researchers present an overview of treatment and management strategies for patients with HR+/HER2+ breast cancer, including common adverse effects.

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

University of Wisconsin’s Carbone Cancer Center recently announced a partnership with TAE Life Sciences, a company that ...

Agenus Inc. (($AGEN)) announced an update on their ongoing clinical study. A recent clinical study update from Agenus Inc. (AGEN) focuses on the ...

What Sets Texas Breast Specialists Apart October is Breast Cancer Awareness Month—a time to remind women about the importance ...

Sellas Life Sciences Group Inc. (NASDAQ:SLS) is a biotechnology company that develops novel cancer therapies. Its lead ...

The study is testing INBRX-106, a hexavalent OX40 agonist antibody, designed to enhance the immune response against tumors. It is administered alone or with pembrolizumab, a well-known anti-PD-1 ...